Internal Medicine, Endocrinology, Diabetes, & Metabolism · Roanoke, VA
NPI
1861526436
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
3 Riverside Cir
Roanoke, VA, 24016
Phone (540) 224-5170
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,661
153 services
Medicare patients, 2024
50
Average age 67
Drug cost, 2024
$341K
938 prescriptions
Company payments, 2023
$21.75
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Israel Hodish was code 99458 (e&m - miscellaneous), 52 times for 21 patients. In total Israel Hodish billed 153 services in 7 codes, and Medicare paid $5,661.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 52 | 21 | $25.41 | $1,321 |
| 99457 E&M - Miscellaneous | Office | 51 | 26 | $32.19 | $1,642 |
| 99214 Office E&M - Established | Office | 28 | 23 | $66.52 | $1,863 |
By year: 2022 $34K for 874 services; 2023 $21K for 542 services; 2024 $5,661 for 153 services.
Medicare prescription drug claims, 2024
In 2024, the drug Israel Hodish prescribed most often to Medicare patients was Atorvastatin Calcium, with 69 prescriptions and refills. In total Israel Hodish wrote 938 Medicare prescriptions that cost $341K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 69 | 197 | 21 | $1,164 |
| Levothyroxine Sodium Generic | 62 | 185 | 17 | $1,051 |
| Metformin Hcl Generic | 40 | 109 | 13 | $566 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 39 | 65 | 13 | $24K |
| Amlodipine Besylate Generic | 29 | 87 | Under 11 | $114 |
| Novolin 70-30 Flexpen Insulin Nph Hum/Reg Insulin Hm | 28 | 52 | Under 11 | $13K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 28 | 65 | Under 11 | $5,514 |
| Losartan Potassium Generic | 28 | 80 | Under 11 | $304 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 26 | 53 | Under 11 | $2,973 |
| Metformin Hcl Er Metformin Hcl | 25 | 52 | Under 11 | $942 |
| Novolin 70-30 Insulin Nph Hum/Reg Insulin Hm | 25 | 34 | Under 11 | $4,089 |
| Ozempic Semaglutide | 24 | 42 | Under 11 | $40K |
| Lisinopril Generic | 24 | 70 | Under 11 | $234 |
| Rosuvastatin Calcium Generic | 22 | 48 | Under 11 | $566 |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 22 | 52 | Under 11 | $17K |
Brand drugs: 368 claims; generic drugs: 456 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Israel Hodish $21.75 ($21.75 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $21.75.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $21.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.